86 related articles for article (PubMed ID: 6640557)
1. Phase I investigation of ametantrone.
Loesch DM; Von Hoff DD; Kuhn J; Coltman CA; Tio F; Chaudhuri TK; Bender JF; Grillo-Lopez AJ
Cancer Treat Rep; 1983 Nov; 67(11):987-91. PubMed ID: 6640557
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of mitoxantrone by 24-hour continuous infusion.
Anderson KC; Garnick MB; Meshad MW; Cohen GI; Pegg WJ; Frei E; Israel M; Modest E; Canellos GP
Cancer Treat Rep; 1983 May; 67(5):435-8. PubMed ID: 6850662
[TBL] [Abstract][Full Text] [Related]
3. High-dose mitoxantrone in metastatic breast cancer: a phase I-II trial.
Leiby JM; Unverfurth DV; Neidhart JA
Cancer Treat Rep; 1986 Jul; 70(7):899-901. PubMed ID: 3719583
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of a 5-day schedule of mitoxantrone (dihydroxyanthracenedione).
Wynert WR; Harvey HA; Lipton A; Schweitzer J; White DS
Cancer Treat Rep; 1982 Jun; 66(6):1303-6. PubMed ID: 7083234
[TBL] [Abstract][Full Text] [Related]
5. A phase of I trial of 4'-epi-Adriamycin.
Schauer PK; Wittes RE; Gralla RJ; Casper ES; Young CW
Cancer Clin Trials; 1981; 4(4):433-7. PubMed ID: 7318126
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of triglycidylurazol given on a 5-day i.v. schedule.
Nicaise C; Rozencweig M; Crespeigne N; Dodion P; Gerard B; Lambert M; Decoster G; Kenis Y
Cancer Treat Rep; 1986 May; 70(5):599-603. PubMed ID: 3708609
[TBL] [Abstract][Full Text] [Related]
7. A phase I trial of ametantrone acetate (NSC-287513).
Gams RA; Ostroy F; Bender JF; Grillo-López AJ
Invest New Drugs; 1985; 3(4):383-8. PubMed ID: 4086246
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of aziridinylbenzoquinone (NSC 182986).
Bedikian AY; Bodey GP; Burgess MA; Freireich EJ
Cancer Clin Trials; 1981; 4(4):459-63. PubMed ID: 7318128
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of dihydroxyanthracenedione.
Van Echo DA; Whitacre MY; Aisner J; Wiernik PH
Cancer Treat Rep; 1981; 65(9-10):831-4. PubMed ID: 7273015
[TBL] [Abstract][Full Text] [Related]
10. Clinical and clinical pharmacologic studies of mitoxantrone.
Stewart JA; McCormack JJ; Krakoff IH
Cancer Treat Rep; 1982 Jun; 66(6):1327-31. PubMed ID: 7083236
[TBL] [Abstract][Full Text] [Related]
11. [Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].
Wakui A; Yokoyama M; Konno K; Nakai Y; Sakano T; Koyama Y; Imamura Y; Nakajima O; Niijima T; Akaza H
Gan To Kagaku Ryoho; 1985 Jan; 12(1):118-24. PubMed ID: 3966806
[TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer.
Osborne CK; Drelichman A; Von Hoff DD; Crawford ED
Cancer Treat Rep; 1983 Dec; 67(12):1133-5. PubMed ID: 6652630
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of mitoxantrone in multiple myeloma: a Southwest Oncology Group Study.
Alberts DS; Balcerzak SP; Bonnet JD; Stephens RL
Cancer Treat Rep; 1985 Nov; 69(11):1321-3. PubMed ID: 4092195
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of aclacinomycin A.
Van Echo DA; Whitacre MY; Aisner J; Applefeld MM; Wiernik PH
Cancer Treat Rep; 1982 May; 66(5):1127-32. PubMed ID: 6952961
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of pentamethylmelamine in patients with previously treated malignancies.
Van Echo DA; Chiuten DF; Whitacre M; Aisner J; Lichtenfeld JL; Wiernik PH
Cancer Treat Rep; 1980; 64(12):1335-9. PubMed ID: 6781747
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of VP-16-213 (Etoposide) administered as a continuous 5-day infusion.
Lokich J; Corkery J
Cancer Treat Rep; 1981; 65(9-10):887-9. PubMed ID: 7273024
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of SOAz.
Nasca S; Jezekova D; Coninx P; Garbe E; Carpentier Y; Cattan A
Cancer Treat Rep; 1982 Dec; 66(12):2039-42. PubMed ID: 7139646
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of ICRF-187 by 48-hour continuous infusion.
Koeller JM; Earhart RH; Davis HL
Cancer Treat Rep; 1981; 65(5-6):459-63. PubMed ID: 6786740
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of intermittent high-dose dacarbazine.
Buesa JM; Gracia M; Valle M; Estrada E; Hidalgo OF; Lacave AJ
Cancer Treat Rep; 1984 Mar; 68(3):499-504. PubMed ID: 6704980
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical trial: pharmacokinetics of a novel anthracycline, DA-125 and metabolites. Single dose study.
Roh JK; Rha SY; Lee CI; Lee KH; Lee JJ; Shim HJ; Lee SD; Kim WB; Yang J; Kim SH; Lee MG
Int J Clin Pharmacol Ther; 1998 Jun; 36(6):312-9. PubMed ID: 9660038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]